BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8817418)

  • 1. Supratentorial primitive neuroectodermal tumors in children.
    Dirks PB; Harris L; Hoffman HJ; Humphreys RP; Drake JM; Rutka JT
    J Neurooncol; 1996 Jul; 29(1):75-84. PubMed ID: 8817418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone.
    Marec-Berard P; Jouvet A; Thiesse P; Kalifa C; Doz F; Frappaz D
    Med Pediatr Oncol; 2002 Feb; 38(2):83-90. PubMed ID: 11813171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
    Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
    J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    McBride SM; Daganzo SM; Banerjee A; Gupta N; Lamborn KR; Prados MD; Berger MS; Wara WM; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1319-23. PubMed ID: 18485615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primitive cerebral neuroectodermal tumors excluding medulloblastomas: a retrospective study of 30 cases.
    Mikaeloff Y; Raquin MA; Lellouch-Tubiana A; Terrier-Lacombe MJ; Zerah M; Bulteau C; Habrand JL; Kalifa C
    Pediatr Neurosurg; 1998 Oct; 29(4):170-7. PubMed ID: 9876245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
    Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
    Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
    Jakacki RI
    Childs Nerv Syst; 1999 Oct; 15(10):586-91. PubMed ID: 10550590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival and prognostic factors analysis of primitive neuroectodermal tumor].
    Shen J; Yuan Y; Hu K; Lian X; Hou XR; Sun S; Yan JF; Liu ZK; Zhang FQ
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):614-618. PubMed ID: 30139033
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. A neurosurgical perspective from the Children's Cancer Group.
    Albright AL; Wisoff JH; Zeltzer P; Boyett J; Rorke LB; Stanley P; Geyer JR; Milstein JM
    Pediatr Neurosurg; 1995; 22(1):1-7. PubMed ID: 7888387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.